ALTITUDE-AD results: What do they mean for the oligomer hypothesis?
Date: 2026-11-04
Alzinova has prepared a Q&A on the Phase 2 ALTITUDE-AD results for sabirnetug, their implications for the amyloid-beta oligomer hypothesis, and how ALZ-101 and ALZ-201 differ in their approach to targeting toxic oligomers.